AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7917442 — intervention group
Group type: COMPARATOR
Intervention: Daily alcohol consumption
Number of subjects: 17824
Study 2816584 — intervention group
Group type: EXPERIMENTAL
Intervention: YAG-laser irradiation
Number of subjects: 0
Study 2816584 — intervention group
Group type: COMPARATOR
Intervention: TUR (Transurethral Resection)
Number of subjects: 0
Study 2816584 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 786362 — intervention group
Group type: EXPERIMENTAL
Intervention: Busulphan
Number of subjects: 726
Study 786362 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 726
Study 786362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 31903692 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0
Study 31601466 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow nucleated cell (BMNc) injection
Number of subjects: 30
Study 31601466 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 30
Study 28619050 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Admission Skåne plus Treatment as Usual
Number of subjects: 124
Study 28619050 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual
Number of subjects: 124
Study 24878846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis
Number of subjects: 0
Study 23234617 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg daily with breakfast for 12 weeks
Number of subjects: 923
Study 23234617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 923
Study 23234617 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 923
Study 21672211 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise therapy (AET) + usual care
Number of subjects: 120
Study 21672211 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) + usual care
Number of subjects: 120
Study 21672211 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study 19419445 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF
Number of subjects: 16
Study 19419445 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+R
Number of subjects: 16
Study 16398727 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochemically treated (PCT) platelets
Number of subjects: 308
Study 16398727 — intervention group
Group type: COMPARATOR
Intervention: Control platelets
Number of subjects: 308
Study 15674006 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (20 minutes, twice weekly, for 12 weeks)
Number of subjects: 0
Study 15674006 — intervention group
Group type: COMPARATOR
Intervention: Friendly visit (control group, reading, talking, playing quiet games, twice weekly for 12 weeks)
Number of subjects: 0
Study 11207018 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position (group 1)
Number of subjects: 38
Study 11207018 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-recumbent position (group 2)
Number of subjects: 38
Study 11207018 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (2 l by nasal cannulae)
Number of subjects: 38
Study 8077977 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cryotherapy at 50 degrees F
Number of subjects: 90
Study 8077977 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cryotherapy at 60 degrees F
Number of subjects: 90
Study 8077977 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cryotherapy at 70 degrees F
Number of subjects: 90
Study 8077977 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (morphine)
Number of subjects: 90
Study 2569600 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 hours of normobaric oxygen (NBO) in group A0 (n = 170)
Number of subjects: 629
Study 2569600 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 hours of hyperbaric oxygen (HBO) at 2 ATA plus 4 hours of NBO in group A1 (n = 173)
Number of subjects: 629
Study 2569600 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 session of HBO in group B1 (n = 145)
Number of subjects: 629
Study 2569600 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sessions of HBO in group B2 (n = 141)
Number of subjects: 629
Study 2569600 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with coma (B1 and B2)
Number of subjects: 629
Study 407788 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum dietary intake (60 to 270 cal/kg per day)
Number of subjects: 0
Study 407788 — intervention group
Group type: COMPARATOR
Intervention: Dietary protein level
Number of subjects: 0
Study 407788 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in dietary intake
Number of subjects: 0
Study 407788 — intervention group
Group type: COMPARATOR
Intervention: Inadequate dietary intake
Number of subjects: 0
Study 31334466 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty
Number of subjects: 120
Study 31334466 — intervention group
Group type: COMPARATOR
Intervention: Total hip arthroplasty
Number of subjects: 120
Study 23657761 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 40
Study 26098847 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB (40 mg/day olmesartan) for eight weeks
Number of subjects: 245
Study 25126036 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile and proprioceptive sensory stimulation (condition 2)
Number of subjects: 18
Study 25126036 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile sensory stimulation only (condition 3)
Number of subjects: 18
Study 25126036 — intervention group
Group type: COMPARATOR
Intervention: No electrical stimulation (condition 1)
Number of subjects: 18
Study 23160273 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered discectomy device used by attending surgeons in levels 9 and 11
Number of subjects: 9
Study 23160273 — intervention group
Group type: COMPARATOR
Intervention: Manual discectomy performed by spine fellows
Number of subjects: 9
Study 23160273 — intervention group
Group type: COMPARATOR
Intervention: Manual discectomy performed by spine attendings
Number of subjects: 9
Study 23160273 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered discectomy device
Number of subjects: 9
Study 19418214 — intervention group
Group type: EXPERIMENTAL
Intervention: StressEraser
Number of subjects: 10
Study 19418214 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 10
Study 17717237 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine 1.5 mg
Number of subjects: 240
Study 17717237 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ondansetron 4 mg
Number of subjects: 240
Study 17717237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 15104206 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol valerate therapy
Number of subjects: 30
Study 15104206 — intervention group
Group type: COMPARATOR
Intervention: Combined HRT with oestradiol valerate and levonorgestrel
Number of subjects: 30
Study 11439290 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 18
Study 9404675 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA (5.4 g daily as ethyl esters)
Number of subjects: 31
Study 9404675 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐Se bread (3 slices daily providing 115 micrograms Se)
Number of subjects: 31
Study 9404675 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for groups 1 and 4)
Number of subjects: 31
Study 9404675 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐Se bread with n‐3 PUFA
Number of subjects: 31
Study 8484499 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) on the P6 point applied 30‐45 min before induction of anesthesia and continued for 6 h postoperatively
Number of subjects: 103
Study 8484499 — intervention group
Group type: COMPARATOR
Intervention: Control group with electrical stimulator turned off
Number of subjects: 103
Study 3040959 — intervention group
Group type: EXPERIMENTAL
Intervention: OrthoMatrix HA‐500
Number of subjects: 12
Study 3040959 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpore 200
Number of subjects: 12
Study 3040959 — intervention group
Group type: COMPARATOR
Intervention: Debrided control
Number of subjects: 12
Study 29415730 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐ and postnatal small‐quantity lipid‐based nutrient supplements for both mother and child
Number of subjects: 432
Study 29415730 — intervention group
Group type: COMPARATOR
Intervention: Prenatal supplementation with iron and folic acid
Number of subjects: 432
Study 29415730 — intervention group
Group type: COMPARATOR
Intervention: Pre‐ and postnatal supplementation with multiple micronutrients
Number of subjects: 432
Study 27464984 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE-27 (10 g/day)
Number of subjects: 0
Study 27464984 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE-54 (10 g/day)
Number of subjects: 0
Study 27464984 — intervention group
Group type: COMPARATOR
Intervention: Inulin (control)
Number of subjects: 0
Study 23822141 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked collagen membrane (VN)
Number of subjects: 19
Study 23822141 — intervention group
Group type: COMPARATOR
Intervention: Native collagen membrane (CM)
Number of subjects: 19
Study 22660367 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day IUC clamping
Number of subjects: 60
Study 22660367 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day IUC clamping
Number of subjects: 60
Study 22660367 — intervention group
Group type: COMPARATOR
Intervention: 0-day IUC removal without clamping
Number of subjects: 60
Study 20554376 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty for osteoporotic burst fractures
Number of subjects: 64
Study 20554376 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous vertebroplasty for osteoporotic compression fractures
Number of subjects: 64
Study 20554376 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement leakage rate
Number of subjects: 64
Study 20554376 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjacent fractures
Number of subjects: 64
Study 18540873 — intervention group
Group type: COMPARATOR
Intervention: Tissue Dielectric Constant (TDC) values at forearm and biceps
Number of subjects: 22
Study 18540873 — intervention group
Group type: COMPARATOR
Intervention: TDC values at axilla, biceps, forearm, and thorax
Number of subjects: 22
Study 18540873 — intervention group
Group type: EXPERIMENTAL
Intervention: TDC values at different depths in forearm
Number of subjects: 22
Study 18540873 — intervention group
Group type: COMPARATOR
Intervention: Dominant-non-dominant side comparisons
Number of subjects: 22
Study 15883282 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 37
Study 15883282 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 37
Study 12670816 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural 10 mL saline injection
Number of subjects: 100
Study 12670816 — intervention group
Group type: COMPARATOR
Intervention: No epidural injection (dry group)
Number of subjects: 100
Study 10053175 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for delirium prevention
Number of subjects: 852
Study 10053175 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (control)
Number of subjects: 852
Study 8595991 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug combinations for Helicobacter pylori eradication
Number of subjects: 0
Study 1572460 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical thrombectomy (TE)
Number of subjects: 20
Study 1572460 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis (TL) using 30 mg rt-PA
Number of subjects: 20
Study 3933523 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin
Number of subjects: 110
Study 3933523 — intervention group
Group type: COMPARATOR
Intervention: Gold sodium thiomalate
Number of subjects: 110
Study 31392214 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight and obesity prevalence among Libyan adults
Number of subjects: 401
Study 30442137 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus-driven CONSORT extension for randomised trials using an adaptive design
Number of subjects: 0
Study 30442137 — intervention group
Group type: EXPERIMENTAL
Intervention: Delphi survey
Number of subjects: 0
Study 30442137 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus meeting
Number of subjects: 0
Study 30442137 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstract checklist
Number of subjects: 0
Study 27681448 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized rescue exercise program conducted for 12 weeks at 3 sessions per week.
Number of subjects: 129
Study 26210907 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 351
Study 26210907 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 351
Study 26210907 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 351
Study 23288762 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial Pivot (MP) prostheses
Number of subjects: 465
Study 23288762 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior and Posterior Cruciate Ligament Retaining (ACL-PCL) prostheses
Number of subjects: 465
Study 23288762 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior Cruciate Ligament (PCL) prostheses
Number of subjects: 465
Study 23288762 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior Cruciate-Substituting (PS) prostheses
Number of subjects: 465
Study 23288762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Bearing (MB) prostheses
Number of subjects: 465
Study 20873910 — intervention group
Group type: EXPERIMENTAL
Intervention: Video teleconferencing (VTC)
Number of subjects: 112
Study 20873910 — intervention group
Group type: COMPARATOR
Intervention: In-person delivery
Number of subjects: 112
Study 19105579 — intervention group
Group type: EXPERIMENTAL
Intervention: STTTTTTT presentation program
Number of subjects: 50
Study 19105579 — intervention group
Group type: EXPERIMENTAL
Intervention: AON learning
Number of subjects: 50
Study 19105579 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental learning
Number of subjects: 50
Study 19105579 — intervention group
Group type: EXPERIMENTAL
Intervention: Unlearned items
Number of subjects: 50
Study 16652311 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted prevention strategy for urinary tract infection in orthopedic surgery patients
Number of subjects: 1328
Study 16652311 — intervention group
Group type: COMPARATOR
Intervention: Abdominal surgery patients (control)
Number of subjects: 1328
Study 12791814 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (40-80 mg/d)
Number of subjects: 32
Study 12791814 — intervention group
Group type: COMPARATOR
Intervention: Control (ACE inhibitor and loop diuretic only)
Number of subjects: 32
Study 11069197 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 1)
Number of subjects: 50
Study 11069197 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 2)
Number of subjects: 50
Study 11069197 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 1, 10 patients who did not respond to etidronate)
Number of subjects: 50
Study 11069197 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 1, 15 patients who did not respond at FN to etidronate)
Number of subjects: 50
Study 8840345 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute cigarette smoking in young smokers
Number of subjects: 40
Study 8840345 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute cigarette smoking in both young and elderly smokers
Number of subjects: 40
Study 8840345 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term smoking history
Number of subjects: 40
Study 8840345 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging effects
Number of subjects: 40
Study 8840345 — intervention group
Group type: COMPARATOR
Intervention: Smoker versus nonsmoker status
Number of subjects: 40
Study 1611181 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) plus amphotericin-B (AMPH) and polymyxin-B (PL)
Number of subjects: 22
Study 1611181 — intervention group
Group type: COMPARATOR
Intervention: Control regimen with polymyxin-B (PL) and amphotericin-B (AMPH) alone
Number of subjects: 22
Study 6203784 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial hormone determinations (beta‐hCG, HPL, P, 17‐OHP, E2 and E3)
Number of subjects: 1125
Study 6203784 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined determination of all hormones
Number of subjects: 1125
Study 6203784 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of beta‐hCG
Number of subjects: 1125
Study 6203784 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of E2 or E3
Number of subjects: 1125
Study 6203784 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods tested
Number of subjects: 1125
Study 6203784 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone determinations
Number of subjects: 1125
Study 30827428 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization (EM); self‐weaned from sling and performed pain‐free active ROM during the first 6 weeks
Number of subjects: 206
Study 30827428 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (SR); wore a sling for 6 weeks with no active ROM
Number of subjects: 206
Study 30827428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EM and SR groups
Number of subjects: 206
Study 30047816 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical Care (PC) group
Number of subjects: 153
Study 30047816 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 153
Study 26742999 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS texting arm (n=22)
Number of subjects: 43
Study 26742999 — intervention group
Group type: COMPARATOR
Intervention: Non-SMS texting arm (n=21)
Number of subjects: 43
Study 24220007 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dimensional neuroendoscopy
Number of subjects: 10
Study 24220007 — intervention group
Group type: EXPERIMENTAL
Intervention: high-definition neuroendoscopy
Number of subjects: 10
Study 24220007 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dimensional and high-definition neuroendoscopy
Number of subjects: 10
Study 22523306 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous BMNCs
Number of subjects: 183
Study 22523306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 20361674 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam 2 mg
Number of subjects: 80
Study 20361674 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 80
Study 17704033 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient fortified salt
Number of subjects: 129
Study 17704033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fortified salt)
Number of subjects: 129
Study 16327472 — intervention group
Group type: EXPERIMENTAL
Intervention: Black polyurethane (PU) foam at negative pressure of 300 mmHg
Number of subjects: 0
Study 16327472 — intervention group
Group type: EXPERIMENTAL
Intervention: White polyvinyl alcohol (PVA) foam at negative pressure of 300 mmHg
Number of subjects: 0
Study 16327472 — intervention group
Group type: COMPARATOR
Intervention: Comparison of blood flow at baseline and at negative pressure of 300 mmHg
Number of subjects: 0
Study 12402733 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 80 mg
Number of subjects: 30
Study 12402733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10087856 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing order information in a short-term memory task
Number of subjects: 0
Study 10087856 — intervention group
Group type: COMPARATOR
Intervention: Short-term memory task without processing order information
Number of subjects: 0
Study 10087856 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar short-term memory task
Number of subjects: 0
Study 7709938 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive measures for osteoporosis
Number of subjects: 0
Study 7709938 — intervention group
Group type: EXPERIMENTAL
Intervention: Current treatments for osteoporosis
Number of subjects: 0
Study 7709938 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions at a much later age
Number of subjects: 0
Study 7709938 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive treatments
Number of subjects: 0
Study 7709938 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of osteoporosis
Number of subjects: 0
Study 2062395 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (optimal medical treatment, training of physical endurance, health education, psychological and social support) for 3 months, 38 hours a week
Number of subjects: 44
Study 2062395 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 44
Study 2062395 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 44
Study 6409919 — intervention group
Group type: EXPERIMENTAL
Intervention: hpGRF44 (0.5 microgram/kg)
Number of subjects: 7
Study 6409919 — intervention group
Group type: EXPERIMENTAL
Intervention: hpGRF44 (5 micrograms/kg)
Number of subjects: 7
Study 6409919 — intervention group
Group type: EXPERIMENTAL
Intervention: hpGRF44 (10 micrograms/kg)
Number of subjects: 7
Study 6409919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 30941490 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PV)
Number of subjects: 180
Study 30941490 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 180
Study 28849338 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer network gender norms
Number of subjects: 1103
Study 28849338 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer network social cohesion
Number of subjects: 1103
Study 26473996 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; 25°C/45% RH, inspired fraction of oxygen = 20.9%)
Number of subjects: 6
Study 26473996 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic (HYP; 25°C/45% RH, inspired fraction of oxygen = 13.3%/simulated altitude of 3600 m)
Number of subjects: 6